CGTX logo

CGTXCognition Therapeutics Inc

$1.20
$0.06
(5.26%)
Today
Closed $1.20
$0.014
(1.17%)
After Hours
Updated: 07:39 PM EDT
Reported EarningsMay 7
Mkt Cap$102.03M
Vol604,328.00
34

Bearish Sentiment

How do you feel about CGTX?

About

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14

Frequently Asked Questions

What is Market Cap of Cognition Therapeutics Inc?
What is the 52-week high for Cognition Therapeutics Inc?
What is the 52-week low for Cognition Therapeutics Inc?
What is Cognition Therapeutics Inc stock price today?
What was Cognition Therapeutics Inc stock price yesterday?
What is the PE ratio of Cognition Therapeutics Inc?
What is the Price-to-Book ratio of Cognition Therapeutics Inc?
What is the 50-day moving average of Cognition Therapeutics Inc?
How many employees does Cognition Therapeutics Inc have?

Advertisement|Remove ads.